Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer

Clinical trial NCT03524508 · COMPLETED

Trial details

NCT number: NCT03524508
Sponsor: Changhoon Yoo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Biliary Tract Cancer

Start date: 2018-09-04
Primary completion: 2020-09-30
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.